Company Filing History:
1 out of 1,010 
1 out of 82 Years Active: 2000
Title: The Innovations of Bob Beekman
Introduction
Bob Beekman is a notable inventor based in Leiden, Netherlands. He has made significant contributions to the field of proteolytic enzyme assays, holding a total of 2 patents. His work has implications in various biological applications, particularly in the detection of collagen degradation.
Latest Patents
One of Bob Beekman's latest patents is a method for assaying proteolytic enzymes using fluorescence-quenched techniques. This patent describes a sandwich-type immunoassay designed for the detection and quantitation of collagen degradation products in biological samples such as blood, serum, plasma, sputum, and cell cultures. The immunoassay employs a first antibody that targets an epitope present on a collagen molecule, located up to 165 amino acids from a collagen telopeptide crosslink site. Additionally, a second antibody is directed at another epitope of the crosslinked collagen molecule, enhancing the assay's specificity and effectiveness.
Career Highlights
Throughout his career, Bob Beekman has worked with esteemed organizations, including the Netherlands Organization for Applied Scientific Research (TNO). His expertise in the field has allowed him to contribute to various research projects and innovations.
Collaborations
Bob has collaborated with notable professionals, including Johannes Maria Te Koppele, further enriching his research and development efforts.
Conclusion
Bob Beekman's contributions to the field of proteolytic enzyme assays and his innovative patents highlight his role as a significant inventor in the scientific community. His work continues to influence research in biological sample analysis and collagen degradation detection.